• Review •
Advances in imaging evaluation of resectability of lymph nodes in breast cancer
Cite this article as: Tan YC, Lü FJ. Advances in imaging evaluation of resectability of lymph nodes in breast cancer. Chin J Magn Reson Imaging, 2020, 11(3): 235-237. DOI:10.12015/issn.1674-8034.2020.03.017.
| [Abstract] Axillary lymph node dissection of breast cancer has different degree of dissection according to different conditions, which requires the detailed imaging results of breast cancer lymph nodes before operation to evaluate its resectability. There are many imaging methods to evaluate the resectability of lymph nodes in breast cancer, including ultrasound, X-ray, CT, MRI, nuclear medicine, etc. MRI has the best diagnostic performance and can provide rich imaging information. In terms of the resectability of lymph nodes in breast cancer, mDIXON technology is applied to axillary vascular imaging to provide detailed information about the relationship between axillary lymph nodes and blood vessels, guide the preoperative evaluation of lymph node dissection in breast cancer and formulate the operation plan, so as to reduce the amount of bleeding. |
| [Keywords] breast neoplasms；lymph nodes；diagnostic imaging |
TAN Yuchuan Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 630014, China; Department of Imaging, Chongqing Cancer Hospital, Chongqing 400030, China
LÜ Fajin* Department of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 630014, China
*Corresponding to: Lü FJ, E-mail: fajinlv@163.com
Conflicts of interest None.
| Received 2019-11-25 |
| Accepted 2020-02-12 |
| DOI: 10.12015/issn.1674-8034.2020.03.017 |
| Cite this article as: Tan YC, Lü FJ. Advances in imaging evaluation of resectability of lymph nodes in breast cancer. Chin J Magn Reson Imaging, 2020, 11(3): 235-237. DOI:10.12015/issn.1674-8034.2020.03.017. |
[1]
师金，梁迪，李道娟，等．全球女性乳腺癌流行情况研究．中国肿瘤, 2017, 26(9): 683-690.
[2]
Esen G, Gurses B, Yilmaz MH, et al. Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol, 2005, 15(10): 1215-1223.
[3]
Yun SJ, Sohn YM, Seo M, et al. Risk factors for false-negative and false-positive results of magnetic resonance computer-aided evaluation in axillary lymph node staging. Comput Assist Tomogr, 2016, 40(6): 928-936.
[4]
杨亦，姚钰，刘家伟，等．多种影像学手段评估乳腺癌患者腋窝淋巴结状态的对比研究．南京医科大学学报（自然科学版), 2019, 39(5): 721-726.
[5]
吴佩琪，刘春玲，刘再，等.钼靶、CT与DCE-MRI评价乳腺癌淋巴结转移的价值．南方医科大学学报, 2016, 36(4): 493-499.
[6]
Stadnik TW, Everaert H, Makkat S. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging—initial findings. Eur Radiol, 2006, 16(10): 2153-2160.
[7]
Kim JY, Kim JJ, Hwangbo L, et al. Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival. Radiology, 2019, 291(2): 300-307.
[8]
陈国宝. 18F-FDG PET/CT诊断浸润性乳腺癌和淋巴结转移的效果.现代医用影像学, 2016, 25(6): 1137-1139.
[9]
Basset Lw. Breast imaging. Philadelphia: Elsevier, 2011: 168-172.
[10]
Yun SJ, Sohn YM, Seo M. Differentiation of benign and metastatic axillary lymph nodes in breast cancer: additive value of MRI computer-aided evaluation. Clin Radiol, 2016, 71(4): 401-403.
[11]
Assing MA, Patel BK, Karamsadkar N, et al. A comparison of the diagnostic caccuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer. Breast J, 2017, 23(6): 647-655.
[12]
[13]
Valente SA, Levine GM, Silverstein MJ, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol, 2012, 19(6): 1825-1830.
[14]
彭徐辉．多层螺旋CT双期增强扫描对乳腺癌及早期淋巴结转移患者的诊断价值．实用癌症杂志, 2016, 31(2): 277-299.
[15]
叶莹莹，张扬，张海静．磁共振技术诊断乳腺癌腋窝淋巴转移的研究进展．实用医技杂志, 2016, 23(1): 56-58.
[16]
张文海．乳腺癌术前腋窝评估与淋巴结清扫方式的选择．中华临床医师杂志, 2015, 9(6): 13-15.
[17]
范惠文，史讯，时坤，等．多层螺旋CT血管成像在乳腺癌手术计划中的临床应用研究．中国医学创新, 2014, 11(20): 32-35.
[18]
Ghouri MA, Gupta N, Bhat AP, et al. CT and MR imaging of the upper extremity vasculature: pearls, pitfalls, and challenges. Cardiovasc Diagn Ther, 2019, 9(Suppl 1): S152-S173.
[19]
Lim RP, Hornsey E, Ranatuga D, et al.Upper extremity non-contrast magnetic resonance venography(MRV) compared to contrast enhanced MRV and ultrasound. Clin Imaging, 2017, 45(05): 51-57.
[20]
Stepansky F, Hecht EM, Rivera R, et al. Dynamic MR angiography of upper extremity vascular disease: pictorial review. Radiographics, 2008, 28(1): e28.
[21]
Connell DA, Koulouris G, Thorn DA, et al. Contrast-enhanced MR angiography of the hand. Radiographics, 2002, 22(3): 583-599.
[22]
Goyen M, Debatin JF. Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing,safety, and efficacy. J Magn Reson Imaging, 2004, 19(3): 261-273.
[23]
Veldoen S, Behzadi C, Derlin T, et al. Exact monitoring of aortic diameters in Marfan patients without gadolinium contrast: intrandicidual comparison of 2D SSFP imaging with 3D CE-MRA and echocardiography. Eur Radiol, 2014, 25(3): 872-882.
[24]
Prince MR. Body MR angiography with gadolinium contrast agents. Magn Reson Imaging Clin N Am, 1996, 4(1): 11-24.
[25]
Pelc NJ, Bernstein MA, Shimakawa A, et al. Encoding strategies for three-direction phase-contrast MR imaging of flow. J Magn Reson Imaging, 1991, 1(4): 405-413.
[26]
Korosec FR, Frayne R, Grist TM, et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med, 1996, 36(3): 345-351.
[27]
Schicchi N, Tagliati C, Agliata G, et al. MRI evaluation of peripheral vascular anomalies using time resolved imaging of contrast kinetics (TRICKS) sequence. Cardiac Radiol, 2018, 123: 563-571.
[28]
Hadizadeh DR, Marx C, Gieseke J, et al. High temporal and high spatial resolution MR angiography (4D-MRA). Fortschr Röntgenstr, 2014, 186(1): 847-859.
[29]
Winterer JB, Blanke P, Schaefer A, et al. Bilateral contrast-enhanced MR angiography of the hand: diagnostic image quality of accelerated MRI using echo sharing with interleaved stochastic trajectories (TWIST). Eur Radiol, 2011, 21(5): 1026-1033.
[30]
Leiner T, Habets J, Versluis B, et al. Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression. Eur Radiol, 2013, 23(8): 2228-2235.
[31]
Lorbeer R, Grotz A, Dorr M, et al. Reference values of vessel diameters, stenosis prevalence, and arterial variations of the lower limb arteries in a male population sample using contrast-enhanced MR angiography. PLoS One, 2018, 6(20): 1-15.
